Numerai Gp LLC Pacific Biosciences Of California, Inc. Transaction History
Numerai Gp LLC
- $232 Billion
- Q1 2024
A detailed history of Numerai Gp LLC transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Numerai Gp LLC holds 25,769 shares of PACB stock, worth $54,887. This represents 0.04% of its overall portfolio holdings.
Number of Shares
25,769Holding current value
$54,887% of portfolio
0.04%Shares
3 transactions
Others Institutions Holding PACB
# of Institutions
292Shares Held
254MCall Options Held
1.47MPut Options Held
1.18M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl33.2MShares$70.7 Million0.41% of portfolio
-
Vanguard Group Inc Valley Forge, PA26.6MShares$56.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY23.4MShares$49.8 Million0.0% of portfolio
-
Madrone Advisors, LLC Menlo Park, CA17.6MShares$37.5 Million9.04% of portfolio
-
Nikko Asset Management Americas, Inc.12.8MShares$27.3 Million0.48% of portfolio
About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
- Ticker PACB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 224,840,992
- Market Cap $479M
- Description
- Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...